Taylor & Francis Group
Browse
Appendix_revised_tracked.docx (71.62 kB)

Lessons learnt from the application of the HEcoPerMed guidance to three modelling case studies - Supplementary material

Download (71.62 kB)
dataset
posted on 2023-09-11, 09:40 authored by Bal ´ azs Nagy, Tam´ as Zelei, Heleen Vellekoop, Simone Huygens, Matthijs Versteegh, Maureen Rutten-van Mo¨ lken, Rositsa Koleva-Kolarova, Apostolos Tsiachristas, Sarah Wordsworth, La´ szlo´ Szilberhorn

Appendix Table 1 Recommendations of the Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine applied in the NTRK case study

Appendix Table 2 Recommendations of the Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine applied in the ToxNav case study

Appendix Table 3 Recommendations of the Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine applied in the MODY case study


Funding

Horizon 2020 Framework Programme, (Grant / Award Number: '824997')

History

Usage metrics

    Personalized Medicine

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC